N4 Pharma PLC
F:0GO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N4 Pharma PLC
F:0GO
|
UK |
|
S
|
Sumitomo Realty & Development Co Ltd
DUS:RL2
|
JP |
|
R
|
Rigolleau SA
BCBA:RIGO
|
AR |
|
I
|
Inogen Inc
F:6IO
|
US |
|
A
|
Allgeier SE
F:AEIN
|
DE |
|
I
|
Industrial and Commercial Bank of China Ltd
XBER:ICK
|
CN |
|
A
|
Accenture PLC
F:CSA
|
IE |
|
H
|
Heidelberg Pharma AG
XHAM:HPHA
|
DE |
|
D
|
Deere & Co
XMUN:DCO
|
US |
|
UFP Technologies Inc
F:UFP
|
US |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
F
|
Ford Motor Co
BMV:F
|
US |
|
Veidekke ASA
F:VK4
|
NO |
|
Schindler Holding AG
F:SHR
|
CH |
|
H
|
Heidelberg Materials AG
MIL:1HEI
|
DE |
|
Healthcare Realty Trust Inc
F:HT0
|
US |
|
L
|
Lowe's Companies Inc
F:LWE
|
US |
|
G
|
Groep Brussel Lambert NV
F:EAI
|
BE |
|
E
|
Equifax Inc
F:EFX
|
US |
Bankruptcy Probability
N4 Pharma PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
N4 Pharma PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
N4 Pharma PLC
LSE:N4P
|
3.7m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
N4 Pharma PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, N4 Pharma PLC has no debt.
You can find a full breakdown on its Balance Sheet.
